Reports world wide Insomnia Market Reports | Page 2

1 KEY TAKEAWAYS
2 DISEASE BACKGROUND
3 Insomnia subtypes
4 TREATMENT
5 Non-medical treatments
6 Medical treatments
7 EPIDEMIOLOGY
8 MARKETED DRUGS
9 Approvals by country
10 PIPELINE DRUGS
11 KEY REGULATORY EVENTS
12 First FDA-Cleared Anti-Insomnia Device To Hit Market In 2017
13 LICENSING AND ASSET ACQUISITION DEALS
14 PARENT PATENTS
15 REVENUE OPPORTUNITY
16 CLINICAL TRIAL LANDSCAPE
17 Sponsors by status
18 Sponsors by phase
19 BIBLIOGRAPHY
20 Prescription information:
21 APPENDIX
LIST OF FIGURES
Figure
Figure
Figure
Figure
Figure
Figure
Figure
Figure
Figure
Figure
Figure
Figure
Figure
1: Trends in prevalent cases of insomnia, 2016–25
2: Overview of pipeline drugs for insomnia in the US
3: Pipeline drugs for insomnia, by company
4: Pipeline drugs for insomnia, by drug type
5: Pipeline drugs for insomnia, by classifications
6: Licensing and asset acquisition deals in insomnia, 2012–17
7: Parent patents in insomnia
8: Clinical trials in insomnia
9: Top 10 drugs for clinical trials in insomnia
10: Top 10 companies for clinical trials in insomnia
11: Trial locations in insomnia
12: Insomnia trials status
13: Insomnia trials sponsors, by phase
LIST OF TABLES